Skip to main content
66°
Cloudy
Site search
Search
Menu
Search
Subscribe
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
Contact Us
Subscribe
News
East Greenwich Pendulum
Kent County Daily Times
Narragansett Times
NK Standard-Times
Sports
Features
Special Sections
Local Guide
Local Events
Markets & Stocks
Weather
Classifieds
Place ad
Legal Notices
Place Kent Legal
Place SRI Class Legal
Search SRI Legals
Search Kent Legals
Obituaries
Subscribe
E-Edition
Community Choice
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Puretech Health Plc ADR
(NQ:
PRTC
)
19.59
UNCHANGED
Streaming Delayed Price
Updated: 3:41 PM EDT, Sep 17, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Puretech Health Plc ADR
< Previous
1
2
3
4
5
Next >
PureTech to Present at 41st Annual J.P. Morgan Healthcare Conference
December 13, 2022
From
PureTech
Via
Business Wire
PureTech Presents Data for LYT-200 Targeting Galectin-9 in Preclinical Leukemia Cancer Models at the 64th American Society of Hematology (ASH) Annual Meeting
December 12, 2022
From
PureTech Health plc
Via
Business Wire
PureTech Founded Entity Sonde Health Raises $19.25 Million Series B for Voice-Based Health Monitoring
December 09, 2022
From
PureTech Health plc
Via
Business Wire
PureTech Announces New Therapeutic Candidate, LYT-310, an Oral Form of Cannabidiol (CBD) Leveraging PureTech’s Glyph™ Platform
November 30, 2022
From
PureTech Health plc
Via
Business Wire
PureTech to Present at Two Upcoming Investor Conferences
November 17, 2022
From
PureTech Health plc
Via
Business Wire
PureTech to Present at the Jefferies London Healthcare Conference
November 09, 2022
From
PureTech Health plc
Via
Business Wire
PureTech to Present at the Credit Suisse 31st Annual Healthcare Conference
November 01, 2022
From
PureTech Health plc
Via
Business Wire
PureTech to Present at the Morgan Stanley Global Healthcare Conference
September 08, 2022
From
PureTech Health plc
Via
Business Wire
PureTech Presents Data for LYT-100 (Deupirfenidone) Supporting Design of Dose-Ranging Trial in Idiopathic Pulmonary Fibrosis (IPF) at European Respiratory Society International Congress 2022
September 06, 2022
From
PureTech Health
Via
Business Wire
PureTech Health plc – Half-Year Report
August 25, 2022
From
PureTech
Via
Business Wire
PureTech Founded Entity Sonde Health Announces Multi-Year Partnership with Koye Pharmaceuticals
August 24, 2022
From
PureTech Health plc
Via
Business Wire
PureTech Health: Notice of Half-Yearly Results
August 04, 2022
From
PureTech Health
Via
Business Wire
PureTech Founded Entity Akili Announces Phase 3 Study of Digital Treatment in Children with ADHD Begun by Shionogi in Japan
August 01, 2022
From
PureTech Health plc
Via
Business Wire
PureTech Founded Entity Akili Announces the Journal Lupus Publishes Investigator-Initiated Study Results Demonstrating Improved Executive Function in Patients with Systemic Lupus Erythematosus Following Use of AKL-T01 Product Candidate
July 14, 2022
From
PureTech Health plc
Via
Business Wire
PureTech Founded Entity Akili Announces Public Company Board of Director Nominees
July 11, 2022
From
PureTech Health plc
Via
Business Wire
PureTech Initiates Late-Stage Clinical Study of Wholly-Owned Candidate LYT-100 (Deupirfenidone) in IPF and Advances LYT-200 (Anti-Galectin-9 mAb)
June 30, 2022
From
PureTech Health plc
Via
Business Wire
PureTech Founded Entity Vedanta Biosciences Unveils State-of-the-Art Manufacturing Facility to Provide Clinical and Commercial Supply of Oral Therapies Based on Defined Bacterial Consortia
June 28, 2022
From
PureTech Health plc
Via
Business Wire
Results of Annual General Meeting
June 15, 2022
From
PureTech Health plc
Via
Business Wire
PureTech Meets Milestone of Achieving Oral Bioavailability of Allopregnanolone in Healthy Adults Dosed with LYT-300
June 14, 2022
From
PureTech Health plc
Via
Business Wire
PureTech Reports Results from Phase 2 Study of LYT-100-COV in Post-Acute “Long” COVID with Respiratory Complications
June 14, 2022
From
PureTech Health plc
Via
Business Wire
PureTech Founded Entity Akili Announces Veteran Life Sciences Executive Matt Franklin in Newly Created Role of President and Chief Operating Officer
June 06, 2022
From
PureTech Health plc
Via
Business Wire
PureTech to Present at the Jefferies Healthcare Conference
June 01, 2022
From
PureTech Health
Via
Business Wire
PureTech Founded Entity Akili Integrates First-of-its-Kind Prescription Video Game Treatment with the Virtual World Through Partnership with Roblox
May 26, 2022
From
PureTech Health plc
Via
Business Wire
PureTech Founded Entity Vedanta Biosciences Presents Data from Multiple Studies at Digestive Disease Week 2022 Annual Meeting
May 24, 2022
From
PureTech Health plc
Via
Business Wire
Vedanta Presents Data from Multiple Studies at Digestive Disease Week 2022 Annual Meeting
May 24, 2022
From
Vedanta Biosciences
Via
Business Wire
PureTech to Present at the UBS Global Healthcare Conference
May 17, 2022
From
PureTech Health plc
Via
Business Wire
PureTech Presents Additional Phase 1 Data for LYT-100 at American Thoracic Society 2022
May 16, 2022
From
PureTech Health plc
Via
Business Wire
PureTech Announces Share Buyback Program Update
May 09, 2022
From
PureTech Health plc
Via
Business Wire
PureTech Announces Share Buyback Program of up to $50 Million
May 05, 2022
From
PureTech Health plc
Via
Business Wire
PureTech Founded Entity Gelesis Announces Clinical Data Demonstrating Weight Loss with GS200 in Adults with Prediabetes and Type 2 Diabetes Presented at the European Congress on Obesity 2022
May 04, 2022
From
PureTech Health plc
Via
Business Wire
< Previous
1
2
3
4
5
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.